T. Rowe Price Associates
CINC

T. Rowe Price Associates’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

T. Rowe Price Associates’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,423,124
Closed -$17.5M – 2989
2022
Q4 		$17.5M Buy
1,423,124
+145,745
+11% +$1.79M ﹤0.01% 946
2022
Q3 		$41.9M Buy
1,277,379
+597,757
+88% +$19.6M 0.01% 699
2022
Q2 		$12.8M Sell
679,622
-39,253
-5% -$740K ﹤0.01% 1276
2022
Q1 		$12.6M Buy
+718,875
New +$12.6M ﹤0.01% 1331